Last quarter (Q4 2023), Sutro Biopharma's total revenue was $113.72M, an increase of 1217.44% from the same quarter last year. In Q4, Sutro Biopharma's net income was $16.06M. See Sutro Biopharma’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Total Revenue	$ 153.73M	$ 153.73M	$ 67.77M	$ 61.88M	$ 42.72M	$ 42.74M
Cost of Revenue	-	-	-	-	-	-
Gross Profit	$ 153.73M	$ 153.73M	$ 67.77M	$ 61.88M	-	-
Operating Expense	$ 243.01M	$ 243.01M	$ 196.72M	$ -160.40M	$ 113.78M	$ 98.20M
Operating Income	$ -89.28M	$ -89.28M	$ -128.94M	$ -98.52M	$ -71.06M	$ -55.47M
Net Non Operating Interest Income Expense	$ -300.00K	$ -1.30M	$ -2.40M	$ 2.60M	$ -2.57M	$ -276.00K
Other Income Expense	$ -21.44M	$ -24.43M	$ -15.59M	$ 7.01M	$ 41.50M	$ -4.35M
Pretax Income	$ -88.60M	$ -88.60M	$ -116.70M	$ -105.54M	$ -32.13M	$ -55.74M
Tax Provision	$ 18.20M	$ 18.20M	$ 2.50M	-	-	-
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -113.09M	$ -106.79M	$ -115.86M	$ -105.54M	$ -32.13M	$ -55.74M
Basic EPS	$ -1.79	$ -1.78	$ -2.35	$ -2.29	$ -0.99	$ -2.43
Diluted EPS	$ -1.79	$ -1.78	$ -2.35	$ -2.29	$ -0.99	$ -2.43
Basic Average Shares	$ 240.65M	$ 60.16M	$ 50.74M	$ 46.12M	$ 32.57M	$ 22.96M
Diluted Average Shares	$ 240.65M	$ 60.16M	$ 50.74M	$ 46.12M	$ 32.57M	$ 22.96M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 243.01M	$ 243.01M	$ 196.72M	$ -160.40M	$ 113.78M	$ 98.20M
Net Income From Continuing And Discontinued Operation	$ -106.79M	$ -106.79M	$ -119.20M	$ -105.54M	$ -32.13M	$ -55.74M
Normalized Income	$ -30.77M	$ -69.99M	$ -92.20M	-	$ -73.63M	$ -55.74M
Interest Expense	-	-	-	-	$ 4.08M	$ 4.35M
EBIT	$ -88.30M	$ -87.30M	$ -114.30M	$ -108.14M	$ -28.05M	$ -51.39M
EBITDA	$ -42.78M	$ -89.58M	$ -108.97M	$ -100.56M	$ -23.75M	$ -46.62M

Currency in USD

Sutro Biopharma Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing